Your browser doesn't support javascript.
loading
Disease severity-based subgrouping of type 2 diabetes does not parallel differences in quality of life: the Maastricht Study.
Werkman, Nikki C C; García-Sáez, Gema; Nielen, Johannes T H; Tapia-Galisteo, Jose; Somolinos-Simón, Francisco J; Hernando, Maria E; Wang, Junfeng; Jiu, Li; Goettsch, Wim G; van der Kallen, Carla J H; Koster, Annemarie; Schalkwijk, Casper G; de Vries, Hein; de Vries, Nanne K; Eussen, Simone J P M; Driessen, Johanna H M; Stehouwer, Coen D A.
Afiliação
  • Werkman NCC; Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, the Netherlands.
  • García-Sáez G; Department of Clinical Pharmacy and Toxicology, Maastricht University Medical Center+, Maastricht, the Netherlands.
  • Nielen JTH; Bioengineering and Telemedicine Group, Centro de Tecnología Biomédica, ETSI de Telecomunicación, Universidad Politécnica de Madrid, Madrid, Spain.
  • Tapia-Galisteo J; Centro de Investigación Biomédica en Red (CIBER)-BBN: Networking Research Center for Bioengineering, Biomaterials and Nanomedicine, Madrid, Spain.
  • Somolinos-Simón FJ; Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, the Netherlands. yannick.nielen@mumc.nl.
  • Hernando ME; Department of Clinical Pharmacy and Toxicology, Maastricht University Medical Center+, Maastricht, the Netherlands. yannick.nielen@mumc.nl.
  • Wang J; Bioengineering and Telemedicine Group, Centro de Tecnología Biomédica, ETSI de Telecomunicación, Universidad Politécnica de Madrid, Madrid, Spain.
  • Jiu L; Centro de Investigación Biomédica en Red (CIBER)-BBN: Networking Research Center for Bioengineering, Biomaterials and Nanomedicine, Madrid, Spain.
  • Goettsch WG; Bioengineering and Telemedicine Group, Centro de Tecnología Biomédica, ETSI de Telecomunicación, Universidad Politécnica de Madrid, Madrid, Spain.
  • van der Kallen CJH; Bioengineering and Telemedicine Group, Centro de Tecnología Biomédica, ETSI de Telecomunicación, Universidad Politécnica de Madrid, Madrid, Spain.
  • Koster A; Centro de Investigación Biomédica en Red (CIBER)-BBN: Networking Research Center for Bioengineering, Biomaterials and Nanomedicine, Madrid, Spain.
  • Schalkwijk CG; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands.
  • de Vries H; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands.
  • de Vries NK; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands.
  • Eussen SJPM; National Health Care Institute, Diemen, the Netherlands.
  • Driessen JHM; Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, the Netherlands.
  • Stehouwer CDA; Department of Internal Medicine, Maastricht University Medical Center+, Maastricht, the Netherlands.
Diabetologia ; 67(4): 690-702, 2024 Apr.
Article em En | MEDLINE | ID: mdl-38206363
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Resistência à Insulina / Complicações do Diabetes / Diabetes Mellitus Tipo 2 Idioma: En Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Resistência à Insulina / Complicações do Diabetes / Diabetes Mellitus Tipo 2 Idioma: En Ano de publicação: 2024 Tipo de documento: Article